{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:50:14Z","timestamp":1787003414582,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["ZIA BC 011065"],"award-info":[{"award-number":["ZIA BC 011065"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["ZIA BC 010008"],"award-info":[{"award-number":["ZIA BC 010008"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["ZIA BC 010008"],"award-info":[{"award-number":["ZIA BC 010008"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["ZIA BC 010008"],"award-info":[{"award-number":["ZIA BC 010008"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["ZIA BC 011065"],"award-info":[{"award-number":["ZIA BC 011065"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001253","name":"Multiple Myeloma Research Foundation","doi-asserted-by":"publisher","award":["Trainee Fellowship Grant"],"award-info":[{"award-number":["Trainee Fellowship Grant"]}],"id":[{"id":"10.13039\/100001253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Data"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiple myeloma, a hematopoietic malignancy of terminally differentiated B cells, is the second most common hematological malignancy after leukemia. While patients have benefited from numerous advances in treatment in recent years resulting in significant increases to average survival time following diagnosis, myeloma remains incurable and relapse is common. To help identify novel therapeutic agents with efficacy against the disease and to search for biomarkers associated with differential response to treatment, a large-scale pharmacological screen was performed with 1,912 small molecule compounds tested at 11 doses for 47 human myeloma cell lines (HMCL). Raw and processed versions of the drug screen dataset are provided, as well as supportive information including drug and cell line metadata and high-level characterization of the most salient features of each. The dataset is publicly available at Zenodo and the workflow code used for data processing and generation of supporting figures and tables are available on GitHub.<\/jats:p>","DOI":"10.1038\/s41597-025-04989-8","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T05:54:26Z","timestamp":1745042066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Large-scale human myeloma cell line small molecule compound screen dataset"],"prefix":"10.1038","volume":"12","author":[{"given":"V. Keith","family":"Hughitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayeh","family":"Gorjifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Michalowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Shinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carleen","family":"Klumpp-Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"McKnight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zina","family":"Itkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Keats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2479-4549","authenticated-orcid":false,"given":"Beverly A.","family":"Mock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"key":"4989_CR1","doi-asserted-by":"publisher","first-page":"e670","DOI":"10.1016\/S2352-3026(22)00165-X","volume":"9","author":"J Huang","year":"2022","unstructured":"Huang, J. et al. The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends. Lancet Haematol. 9, e670\u2013e677 (2022).","journal-title":"Lancet Haematol."},{"key":"4989_CR2","unstructured":"Myeloma - Cancer Stat Facts. SEER https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html."},{"key":"4989_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1158\/2643-3230.BCD-23-0062","volume":"5","author":"SJ Welsh","year":"2023","unstructured":"Welsh, S. J. et al. Transcriptional heterogeneity overcomes super-enhancer disrupting drug combinations in multiple myeloma. Blood Cancer Discov. 5, 34\u201355 (2023).","journal-title":"Blood Cancer Discov."},{"key":"4989_CR4","doi-asserted-by":"crossref","unstructured":"Meermeier, E. W., Bergsagel, P. L. & Chesi, M. Next-generation therapies for multiple myeloma. Annu. Rev. Cancer Biol. 8 (2024).","DOI":"10.1146\/annurev-cancerbio-061421-014236"},{"key":"4989_CR5","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3324\/haematol.2020.247015","volume":"105","author":"A Gulla","year":"2020","unstructured":"Gulla, A. & Anderson, K. C. Multiple myeloma: the (r)evolution of current therapy and a glance into future. Haematologica 105, 2358\u20132367 (2020).","journal-title":"Haematologica"},{"key":"4989_CR6","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1016\/j.drudis.2019.09.019","volume":"24","author":"R Huang","year":"2019","unstructured":"Huang, R. et al. The NCATS Pharmaceutical Collection: a 10-year update. Drug Discov. Today 24, 2341\u20132349 (2019).","journal-title":"Drug Discov. Today"},{"key":"4989_CR7","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1073\/pnas.1311846111","volume":"111","author":"LA Mathews Griner","year":"2014","unstructured":"Mathews Griner, L. A. et al. High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells. Proc. Natl. Acad. Sci. USA. 111, 2349\u20132354 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"4989_CR8","doi-asserted-by":"publisher","first-page":"216284","DOI":"10.1016\/j.canlet.2023.216284","volume":"568","author":"TJ Peat","year":"2023","unstructured":"Peat, T. J. et al. Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma. Cancer Lett. 568, 216284 (2023).","journal-title":"Cancer Lett."},{"key":"4989_CR9","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.14902712","author":"VK Hughitt","year":"2025","unstructured":"Hughitt, VK., Simmons, J., & Mock, B. Human Myeloma Cell Line (HMCL) NCATS MIPE 4.0 Drug Screen Dataset, Zenodo, https:\/\/doi.org\/10.5281\/zenodo.14902712 (2025)."},{"key":"4989_CR10","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1158\/1535-7163.MCT-17-0171","volume":"16","author":"JK Simmons","year":"2017","unstructured":"Simmons, J. K. et al. Cooperative Targets of Combined mTOR\/HDAC Inhibition Promote MYC Degradation. Mol. Cancer Ther. 16, 2008\u20132021 (2017).","journal-title":"Mol. Cancer Ther."},{"key":"4989_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11940-4","volume":"7","author":"B Mazoure","year":"2017","unstructured":"Mazoure, B., Nadon, R. & Makarenkov, V. Identification and correction of spatial bias are essential for obtaining quality data in high-throughput screening technologies. Sci. Rep. 7, 11921 (2017).","journal-title":"Sci. Rep."},{"key":"4989_CR12","doi-asserted-by":"publisher","first-page":"e0146021","DOI":"10.1371\/journal.pone.0146021","volume":"10","author":"C Ritz","year":"2015","unstructured":"Ritz, C., Baty, F., Streibig, J. C. & Gerhard, D. Dose-Response Analysis Using R. PLoS One 10, e0146021 (2015).","journal-title":"PLoS One"},{"key":"4989_CR13","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1093\/bioinformatics\/bts480","volume":"28","author":"J K\u00f6ster","year":"2012","unstructured":"K\u00f6ster, J. & Rahmann, S. Snakemake\u2014a scalable bioinformatics workflow engine. Bioinformatics 28, 2520\u20132522 (2012).","journal-title":"Bioinformatics"},{"key":"4989_CR14","doi-asserted-by":"publisher","unstructured":"R Development Core Team, R. R: A Language and Environment for Statistical Computing. https:\/\/doi.org\/10.1007\/978-3-540-74686-7 (R Foundation for Statistical Computing, 2024).","DOI":"10.1007\/978-3-540-74686-7"},{"key":"4989_CR15","unstructured":"Wickham, H. ggplot2. (Springer New York, New York, NY, 2009)."},{"key":"4989_CR16","doi-asserted-by":"publisher","first-page":"e0087121","DOI":"10.1128\/MRA.00871-21","volume":"10","author":"JL Steenwyk","year":"2021","unstructured":"Steenwyk, J. L. & Rokas, A. Ggpubfigs: Colorblind-friendly color palettes and ggplot2 graphic system extensions for publication-quality scientific figures. Microbiol. Resour. Announc. 10, e0087121 (2021).","journal-title":"Microbiol. Resour. Announc."},{"key":"4989_CR17","unstructured":"Frictionless Data Package (v2). https:\/\/datapackage.org\/standard\/data-package\/."}],"container-title":["Scientific Data"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41597-025-04989-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41597-025-04989-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41597-025-04989-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T05:54:30Z","timestamp":1745042070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41597-025-04989-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4989"],"URL":"https:\/\/doi.org\/10.1038\/s41597-025-04989-8","relation":{"references":[{"id-type":"doi","id":"10.5281\/zenodo.14902712","asserted-by":"subject"}]},"ISSN":["2052-4463"],"issn-type":[{"value":"2052-4463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,19]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"661"}}